CytomX Therapeutics, Inc.

NasdaqGS:CTMX Stock Report

Mkt Cap: US$167.2m

CytomX Therapeutics Future Growth

How is CytomX Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


25.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:CTMX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202555-36-3N/A5
12/31/202455-31-33-755
12/31/202360-49-48-818
9/30/202272-98-142-141N/A
6/30/202273-97-138-136N/A
3/31/202271-92-132-130N/A
12/31/202170-84-121-119N/A
9/30/202166-72-107-105N/A
6/30/202166-64-103-100N/A
3/31/202167-612325N/A
12/31/2020100-3335N/A
9/30/202092-54-9-7N/A
6/30/202085-63-8-5N/A
3/31/202078-76-154-151N/A
12/31/201957-102-144-140N/A
9/30/201961-99-144-140N/A
6/30/201962-99-126-122N/A
3/31/201975-83-105-100N/A
12/31/201860-85-79-76N/A
9/30/201875-52-28-25N/A
6/30/201887-39-27-25N/A
3/31/201874-50173175N/A
12/31/201772-43169170N/A
9/30/201751-58148150N/A
6/30/201730-62139142N/A
3/31/201724-51-18-16N/A
12/31/201615-59-4-2N/A
9/30/201611-57-14-12N/A
6/30/20169-57N/A-6N/A
3/31/20168-50N/A-28N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CTMX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CTMX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CTMX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CTMX's revenue (1.7% per year) is forecast to grow slower than the US market (6.9% per year).

High Growth Revenue: CTMX's revenue (1.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CTMX's Return on Equity is forecast to be high in 3 years time


Discover growth companies